Cargando…
Beneficiality of combined levetiracetam, clonazepam for myoclonus in MERRF requires further confirmation
Autor principal: | Finsterer, Josef |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6415986/ https://www.ncbi.nlm.nih.gov/pubmed/30807362 http://dx.doi.org/10.1097/CM9.0000000000000042 |
Ejemplares similares
-
Photosensitive Epilepsy and Polycystic Ovary Syndrome as Manifestations of MERRF
por: Finsterer, Josef
Publicado: (2020) -
Stimulus-induced myoclonus treated effectively with clonazepam in genetically confirmed Coffin–Lowry syndrome()
por: Arslan, Elif Acar, et al.
Publicado: (2014) -
Diagnosing Kearns-Sayre Syndrome Requires Genetic Confirmation
por: Finsterer, Josef, et al.
Publicado: (2016) -
Pathogenicity of the Homoplasmic m.8701A>G Variant Requires Confirmation
por: Finsterer, Josef, et al.
Publicado: (2016) -
Suppression of Myoclonus in Corticobasal Degeneration by Levetiracetam
por: Cho, Jae Wook, et al.
Publicado: (2014)